23 May 2013
Keywords: insmed, somatokine, granted, priority, review, fda, biopharmaceutical
Article | 22 April 2005
US biopharmaceutical firm Insmed says it has received priority review notification from the US Food and Drug Administration for its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 April 2005
© 2013 thepharmaletter.com